Loading market dashboard
Incyte Corporation
INCYHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Incyte Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $4.56B | $4.34B - $5.06B | $979.57M | $3.463 | 11 |
| Dec 2029 | $4.52B | $4.31B - $5.02B | $971.70M | $3.434 | 11 |
| Dec 2028 | $6.45B | $6.41B - $6.49B | $1.39B | $9.403 | 20 |
| Dec 2027 | $6.17B | $5.76B - $7.22B | $1.33B | $8.887 | 19 |
| Dec 2026 | $5.62B | $5.54B - $5.80B | $1.21B | $7.526 | 18 |
| Dec 2025 | $4.98B | $4.91B - $5.01B | $1.07B | $6.76 | 16 |
| Dec 2024 | $4.20B | $4.14B - $4.23B | $903.90M | $1.276 | 16 |
| Dec 2023 | $3.77B | $3.60B - $4.21B | $810.13M | $3.328 | 15 |
| Dec 2022 | $3.34B | $3.22B - $3.47B | $688.06M | $1.76 | 6 |
| Dec 2021 | $2.92B | $2.82B - $3.04B | $601.81M | $2.584 | 6 |
| Dec 2020 | $2.54B | $2.45B - $2.64B | -$3.80B | -$1.314 | 11 |
| Dec 2019 | $2.16B | $2.08B - $2.24B | $357.78M | $1.885 | 6 |